ArticleInflammopharmacology2025
Nimesulide and sodium hyaluronate ameliorate the inflammatory process and pain severity in traumatic knee osteoarthritis.
Article in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Photobiomodulation Therapy Modulates Inflammatory and Cartilage Biomarkers in Patients with Knee Osteoarthritis: A Pilot Case Series.Journal of orthopaedic case reports · 2026Article
- Targeting subchondral osteoporosis in osteoarthritis: biomechanical crosstalk and the therapeutic rationale for inflammatory microenvironment remodeling.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe objective of this study was to comprehensively analyze the therapeutic effects of combined oral nimesulide and sodium hyaluronate on inflammatory factors (metalloproteinase [MMP]-3, MMP-9, interleukin [IL]-1, and tumor necrosis factor [TNF]-α) and pain intensity in traumatic knee osteoarthritis (TKO).
methodsA total of 100 patients with TKO were enrolled into an experimental (Exp) group (oral nimesulide sustained-release capsule + injection of sodium hyaluronate into the knee cavity) and a control (Ctrl) group (oral nimesulide sustained-release capsules), with 50 cases in each group. The visual analog scale (VAS) score, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores, inflammatory factors, quality of life and clinical efficacy were compared between the two groups.
resultsVAS and WOMAC scores of patients in the Exp group after treatment were greatly lower in contrast to those in the Ctrl group (P < 0.05). Meanwhile, the levels of MMP-3, MMP-9, interleukin (IL)-1, and tumor necrosis factor α (TNF-α) in the joint fluid of patients in the Exp group after treatment were markedly lower and exhibited obvious difference with those in the Ctrl group (P < 0.05). Additionally, the overall treatment effectiveness (OTE) in the Exp group was remarkably higher, which demonstrated a visible difference in comparison to the OTE in the Ctrl group (P < 0.05). The Exp group exhibited significantly higher scores in physical function, social function, and mental health after 1, 2, and 3 years of treatment compared to the Ctrl group. Additionally, the score for bodily pain was significantly lower in the Exp group than in the Ctrl group (P < 0.05).
conclusionThe combination of nimesulide and intra-articular injection of sodium hyaluronate effectively reduced pain intensity and the severity of arthritis in patients, thereby enhancing clinical efficacy.
Indexed as
Identifiers
40495037What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.